GO:0016020 | membrane | 1.24e-05 | 1.22e-01 | 2.654 | 7 | 38 | 1207 |
GO:0005730 | nucleolus | 1.32e-05 | 1.29e-01 | 2.642 | 7 | 41 | 1217 |
GO:0010467 | gene expression | 5.08e-05 | 4.96e-01 | 3.342 | 5 | 31 | 535 |
GO:0000398 | mRNA splicing, via spliceosome | 1.74e-04 | 1.00e+00 | 4.668 | 3 | 8 | 128 |
GO:0044822 | poly(A) RNA binding | 3.45e-04 | 1.00e+00 | 2.763 | 5 | 25 | 799 |
GO:0015030 | Cajal body | 3.69e-04 | 1.00e+00 | 6.083 | 2 | 2 | 32 |
GO:0008380 | RNA splicing | 3.69e-04 | 1.00e+00 | 4.302 | 3 | 7 | 165 |
GO:0005654 | nucleoplasm | 5.32e-04 | 1.00e+00 | 2.631 | 5 | 55 | 876 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 8.68e-04 | 1.00e+00 | 5.469 | 2 | 3 | 49 |
GO:1990259 | histone-glutamine methyltransferase activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:1990258 | histone glutamine methylation | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0016074 | snoRNA metabolic process | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0005681 | spliceosomal complex | 1.09e-03 | 1.00e+00 | 5.302 | 2 | 2 | 55 |
GO:0003723 | RNA binding | 1.20e-03 | 1.00e+00 | 3.720 | 3 | 11 | 247 |
GO:0071013 | catalytic step 2 spliceosome | 1.34e-03 | 1.00e+00 | 5.153 | 2 | 5 | 61 |
GO:0001649 | osteoblast differentiation | 1.97e-03 | 1.00e+00 | 4.874 | 2 | 2 | 74 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0001652 | granular component | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0031428 | box C/D snoRNP complex | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0000212 | meiotic spindle organization | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0005827 | polar microtubule | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0003924 | GTPase activity | 5.01e-03 | 1.00e+00 | 4.189 | 2 | 3 | 119 |
GO:0001055 | RNA polymerase II activity | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 6 |
GO:0016032 | viral process | 5.76e-03 | 1.00e+00 | 2.927 | 3 | 32 | 428 |
GO:0006184 | GTP catabolic process | 5.96e-03 | 1.00e+00 | 4.061 | 2 | 3 | 130 |
GO:0000812 | Swr1 complex | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 7 |
GO:0031122 | cytoplasmic microtubule organization | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 8 |
GO:0031011 | Ino80 complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 8 |
GO:0008266 | poly(U) RNA binding | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 10 |
GO:0043968 | histone H2A acetylation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 10 |
GO:0001054 | RNA polymerase I activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 10 |
GO:0016071 | mRNA metabolic process | 1.00e-02 | 1.00e+00 | 3.674 | 2 | 21 | 170 |
GO:0007020 | microtubule nucleation | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 12 |
GO:0071392 | cellular response to estradiol stimulus | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0035066 | positive regulation of histone acetylation | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0016070 | RNA metabolic process | 1.21e-02 | 1.00e+00 | 3.529 | 2 | 21 | 188 |
GO:0006386 | termination of RNA polymerase III transcription | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 14 |
GO:0010243 | response to organonitrogen compound | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 14 |
GO:0019843 | rRNA binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 14 |
GO:0005525 | GTP binding | 1.33e-02 | 1.00e+00 | 3.461 | 2 | 5 | 197 |
GO:0005829 | cytosol | 1.34e-02 | 1.00e+00 | 1.602 | 5 | 58 | 1787 |
GO:0006281 | DNA repair | 1.41e-02 | 1.00e+00 | 3.418 | 2 | 19 | 203 |
GO:0005719 | nuclear euchromatin | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0005839 | proteasome core complex | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 9 | 16 |
GO:0004298 | threonine-type endopeptidase activity | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 9 | 17 |
GO:0003678 | DNA helicase activity | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 3 | 18 |
GO:0071339 | MLL1 complex | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 18 |
GO:0000794 | condensed nuclear chromosome | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 3 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 20 |
GO:0043967 | histone H4 acetylation | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 2 | 22 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0008033 | tRNA processing | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 2 | 27 |
GO:0034644 | cellular response to UV | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 28 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 29 |
GO:0031490 | chromatin DNA binding | 2.82e-02 | 1.00e+00 | 5.129 | 1 | 1 | 31 |
GO:0014070 | response to organic cyclic compound | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 2 | 35 |
GO:0000278 | mitotic cell cycle | 3.20e-02 | 1.00e+00 | 2.789 | 2 | 35 | 314 |
GO:0000226 | microtubule cytoskeleton organization | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 36 |
GO:0022625 | cytosolic large ribosomal subunit | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 36 |
GO:0040008 | regulation of growth | 3.36e-02 | 1.00e+00 | 4.874 | 1 | 2 | 37 |
GO:0032508 | DNA duplex unwinding | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 5 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 6 | 40 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 40 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.72e-02 | 1.00e+00 | 4.726 | 1 | 16 | 41 |
GO:0003684 | damaged DNA binding | 3.72e-02 | 1.00e+00 | 4.726 | 1 | 9 | 41 |
GO:0004386 | helicase activity | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 2 | 42 |
GO:0042802 | identical protein binding | 3.99e-02 | 1.00e+00 | 2.616 | 2 | 7 | 354 |
GO:0005634 | nucleus | 4.18e-02 | 1.00e+00 | 1.004 | 6 | 67 | 3246 |
GO:0000502 | proteasome complex | 4.25e-02 | 1.00e+00 | 4.529 | 1 | 17 | 47 |
GO:0032481 | positive regulation of type I interferon production | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 5 | 48 |
GO:0006310 | DNA recombination | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 6 | 50 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 17 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 9 | 53 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 17 | 53 |
GO:0070062 | extracellular vesicular exosome | 4.92e-02 | 1.00e+00 | 1.403 | 4 | 43 | 1641 |
GO:0006338 | chromatin remodeling | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 17 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 5.13e-02 | 1.00e+00 | 4.251 | 1 | 16 | 57 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.40e-02 | 1.00e+00 | 4.177 | 1 | 17 | 60 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 16 | 61 |
GO:0019083 | viral transcription | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 2 | 61 |
GO:0006415 | translational termination | 5.66e-02 | 1.00e+00 | 4.106 | 1 | 2 | 63 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.84e-02 | 1.00e+00 | 4.061 | 1 | 17 | 65 |
GO:0006364 | rRNA processing | 6.01e-02 | 1.00e+00 | 4.017 | 1 | 4 | 67 |
GO:0005200 | structural constituent of cytoskeleton | 6.10e-02 | 1.00e+00 | 3.996 | 1 | 2 | 68 |
GO:0006414 | translational elongation | 6.19e-02 | 1.00e+00 | 3.975 | 1 | 2 | 69 |
GO:0051082 | unfolded protein binding | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 4 | 70 |
GO:0006325 | chromatin organization | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 3 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 16 | 70 |
GO:0016363 | nuclear matrix | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 7 | 73 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 6.88e-02 | 1.00e+00 | 3.817 | 1 | 2 | 77 |
GO:0019058 | viral life cycle | 6.97e-02 | 1.00e+00 | 3.798 | 1 | 3 | 78 |
GO:0030529 | ribonucleoprotein complex | 7.31e-02 | 1.00e+00 | 3.726 | 1 | 4 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.48e-02 | 1.00e+00 | 3.691 | 1 | 3 | 84 |
GO:0000209 | protein polyubiquitination | 8.17e-02 | 1.00e+00 | 3.560 | 1 | 16 | 92 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 5 | 97 |
GO:0006457 | protein folding | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 4 | 97 |
GO:0006413 | translational initiation | 8.77e-02 | 1.00e+00 | 3.454 | 1 | 4 | 99 |
GO:0016887 | ATPase activity | 8.85e-02 | 1.00e+00 | 3.440 | 1 | 6 | 100 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.28e-02 | 1.00e+00 | 3.369 | 1 | 18 | 105 |
GO:0003735 | structural constituent of ribosome | 9.61e-02 | 1.00e+00 | 3.315 | 1 | 2 | 109 |
GO:0000790 | nuclear chromatin | 9.61e-02 | 1.00e+00 | 3.315 | 1 | 3 | 109 |
GO:0006397 | mRNA processing | 9.70e-02 | 1.00e+00 | 3.302 | 1 | 2 | 110 |
GO:0042981 | regulation of apoptotic process | 9.87e-02 | 1.00e+00 | 3.276 | 1 | 18 | 112 |
GO:0016607 | nuclear speck | 1.07e-01 | 1.00e+00 | 3.153 | 1 | 3 | 122 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.10e-01 | 1.00e+00 | 3.118 | 1 | 24 | 125 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.24e-01 | 1.00e+00 | 2.934 | 1 | 2 | 142 |
GO:0005622 | intracellular | 1.26e-01 | 1.00e+00 | 2.904 | 1 | 1 | 145 |
GO:0005515 | protein binding | 1.26e-01 | 1.00e+00 | 0.659 | 6 | 76 | 4124 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.39e-01 | 1.00e+00 | 2.753 | 1 | 4 | 161 |
GO:0000166 | nucleotide binding | 1.51e-01 | 1.00e+00 | 2.624 | 1 | 6 | 176 |
GO:0006412 | translation | 1.53e-01 | 1.00e+00 | 2.608 | 1 | 3 | 178 |
GO:0008152 | metabolic process | 1.56e-01 | 1.00e+00 | 2.576 | 1 | 3 | 182 |
GO:0043234 | protein complex | 1.78e-01 | 1.00e+00 | 2.369 | 1 | 8 | 210 |
GO:0005813 | centrosome | 1.83e-01 | 1.00e+00 | 2.322 | 1 | 8 | 217 |
GO:0006200 | ATP catabolic process | 1.85e-01 | 1.00e+00 | 2.309 | 1 | 8 | 219 |
GO:0005524 | ATP binding | 1.96e-01 | 1.00e+00 | 1.283 | 2 | 23 | 892 |
GO:0005925 | focal adhesion | 2.32e-01 | 1.00e+00 | 1.944 | 1 | 4 | 282 |
GO:0043066 | negative regulation of apoptotic process | 2.61e-01 | 1.00e+00 | 1.753 | 1 | 20 | 322 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.74e-01 | 1.00e+00 | 1.670 | 1 | 6 | 341 |
GO:0044267 | cellular protein metabolic process | 2.81e-01 | 1.00e+00 | 1.624 | 1 | 5 | 352 |
GO:0006915 | apoptotic process | 3.21e-01 | 1.00e+00 | 1.400 | 1 | 21 | 411 |
GO:0045087 | innate immune response | 3.47e-01 | 1.00e+00 | 1.263 | 1 | 7 | 452 |
GO:0005737 | cytoplasm | 4.54e-01 | 1.00e+00 | 0.306 | 3 | 50 | 2633 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.59e-01 | 1.00e+00 | 0.753 | 1 | 8 | 644 |
GO:0044281 | small molecule metabolic process | 5.57e-01 | 1.00e+00 | 0.362 | 1 | 32 | 844 |
GO:0003677 | DNA binding | 6.01e-01 | 1.00e+00 | 0.196 | 1 | 18 | 947 |
GO:0006351 | transcription, DNA-templated | 6.50e-01 | 1.00e+00 | 0.012 | 1 | 9 | 1076 |
GO:0005886 | plasma membrane | 8.37e-01 | 1.00e+00 | -0.717 | 1 | 11 | 1784 |